男友太凶猛1v1高h,大地资源在线资源免费观看 ,人妻少妇精品视频二区,极度sm残忍bdsm变态

Global EditionASIA 中文雙語Fran?ais
Business
Home / Business / The Third China International Import Expo

Wuxi's I?Campus signs deals with 12 companies at CIIE

By Liu Zhihua | chinadaily.com.cn | Updated: 2020-11-08 11:49
Share
Share - WeChat
Twelve new companies joined Wuxi International Life Science Innovation Campus (I?Campus) at the 3rd CIIE in Shanghai. [Photo provided to chinadaily.com.cn]

Wuxi International Life Science Innovation Campus (I?Campus), an innovation incubation platform co-built by Wuxi municipal government in Jiangsu province, Wuxi Hi-tech District and AstraZeneca, signed up 12 new innovative companies from home and abroad, secured two innovative partnerships with resident companies, and unveiled several significant inaugurations and signing ceremonies at the 3rd China International Import Expo.

Government officials, including Hui Jianlin, vice-governor of Jiangsu provincial, Helena Sangeland, Swedish ambassador to China, Jiang Min, deputy mayor of Wuxi city, attended the ceremonies, together with executives from AstraZeneca, such as Leon Wang, executive vice-president of AstraZeneca and president of its China arm, and Michael Lai, general manager of AstraZeneca China, and representatives from signing companies.

Supported by Wuxi municipal government and Wuxi Hi-tech District, I?Campus held its opening ceremony in September 2019 and began full business operation in April 2020. Despite the pandemic, I?Campus has been able to maintain close ties with domestic and foreign partners, through which it managed to introduce innovative forces into China and empower the growth of its resident companies.

During the ongoing CIIE, Wuxi government, AstraZeneca, Tigermed, CICC and other companies jointly released the plan for "Wuxi International Health Investment and Innovation Summit". I?Campus itself entered strategic cooperation with BioVenture Hub from Sweden on medical innovation, facilitating further industrial integration and development of healthcare innovation. 

Wang from AstraZeneca said, "The CIIE provides an excellent platform for empowering bilateral innovation exchange and cooperation between domestic and foreign partners.

"We are seeking more partners to build a global healthcare innovation ecosystem characterized by openness, collaboration, and mutual benefits, seeking to grow our own business while contributing to the strengthening of China's healthcare innovation capability and benefiting patients in China and beyond."

Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
CLOSE
 
主站蜘蛛池模板: 卢龙县| 自治县| 怀安县| 新化县| 田林县| 梨树县| 徐闻县| 隆化县| 犍为县| 大方县| 抚顺市| 泸州市| 阿勒泰市| 湘潭市| 明光市| 怀来县| 五河县| 襄樊市| 临江市| 泉州市| 古浪县| 黄骅市| 东辽县| 木里| 华宁县| 衡阳市| 濮阳县| 京山县| 聂拉木县| 叶城县| 黔江区| 平阴县| 黔西县| 连江县| 靖远县| 建平县| 格尔木市| 佛学| 卢龙县| 韶山市| 刚察县|